Themis Medicare LimitedNSE: THEMISMED

Press Release Mar 21 2022

· Issued by Themis Medicare Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-21-2022-14

Themis Medicare Limited has informed the Exchange about press release dated 21-Mar-2022 titled Indian regulator approves VIRALEX for the treatment of mild to moderate COVID-19 in India

View Attachment

6ix hasn’t read this filing yet.

Themis Medicare Limited on 6ix

Earlier from Themis Medicare

Later from Themis Medicare

All Themis Medicare news releases